Lung Function Tests Market to significant growth through 2017-2023|Key players- CareFusion Corporation (U.S.), MGC Diagnostic Corporation (U.S.), General Electric Company (U.S.), Perkin Elmer (U.S), Carestream Health, Inc. (U.S.), COSMED srl (Italy)

Market Synopsis of the Global Lung Function Tests Market
Lung function tests, also known as pulmonary function test is used for the diagnosis of lung disorders such as asthma, respiratory infections, chronic obstructive pulmonary disease (COPD), and others. These group of tests also determine the functioning of the lungs, and the ability of a person to breath. They are also a part of tests for routine examination by the healthcare provider. The healthcare provider may recommend lung function tests to diagnose the suspected lung disease, plan the treatment, and decide whether to continue the ongoing treatment or change it and even to stop the treatment, if required. Therefore, lung function test plays a vital role in the diagnosis of various respiratory diseases, and lung disorders.
View Reports Sample @ https://www.marketresearchfuture.com/sample_request/4828

Rising prevalence of lung diseases such as asthma, COPD, and others, availability of lung function test devices, and increasing demand for lung function test are important factors accelerating the growth of the market. Technological advancements in the lung testing, and growing geriatric population are also influencing the market growth. Changing lifestyle, and smoking addiction are leading to number of lung problems such as lung cancer, which is further driving the growth of the market.
The global lung function tests market is expected to grow at a CAGR of 5.7% during the forecast period.
Segments
The global lung function tests market is segmented on the basis of type, indication, devices, and end user.
On the basis of the type, the market is segmented into spirometry, gas diffusion test, body plethysmograph, bronchial provocation test, and others.
On the basis of the indication, the market is segmented into asthma, chronic bronchitis, respiratory infections, chronic obstructive pulmonary disease, cystic fibrosis, pneumonia, lung cancer, and others.
On the basis of the devices, the market is segmented into spirometer, breath CO monitor, oscillometer, ergospirometer, dose controlled drug nebulizer, and others.
On the basis of the end user, the market is segmented into hospitals, clinics, diagnostic centers, and others.
Regional Analysis of the Global Lung Function Tests Market
America is the leading market for lung function tests owing to the rising prevalence of various types of allergies in the U.S. According to the American College of Allergy Asthma and Immunology, allergic asthma, food allergy, and eczema are the most common types of allergies in the U.S. It further stated that 1 in every 12 people is suffering from allergic rhinitis in the U.S.
Europe is the second largest market for lung function tests. In Europe, the prevalence of allergic conditions is found to be increasing rapidly. Therefore, rising prevalence of allergic conditions such as asthma, food allergy, and anaphylaxis is increasing demand for diagnostic services. Furthermore, rising awareness regarding available treatments and skin testing are fueling the growth of the market. As per European Academy of Allergy and Clinical Immunology, 150 million EU citizens have chronic allergic disease. Additionally, 100 million Europeans have allergic rhinitis.
The Asia Pacific market is expected to grow at the fastest pace and is driven by the high prevalence of asthma, rising geriatric population, and increasing environmental population. Weak immune system and high prevalence of asthma are major risk factors for allergies among elderly population. Additionally, prevalence of COPD is also on the rise, which is boosting the growth of the market.
The Middle East & Africa also show a steady rise in the market owing to high prevalence of chronic respiratory diseases like asthma, and improving healthcare infrastructure. Increasing demand for diagnostic services also influences the market growth in the Middle East & African countries.
Request Full Report @ https://www.marketresearchfuture.com/reports/lung-function-tests-market-4828

Table Of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation

Key Players in the Global Lung Function Tests Market
Some of the key players in this market are CareFusion Corporation (U.S.), MGC Diagnostic Corporation (U.S.), General Electric Company (U.S.), Perkin Elmer (U.S), Carestream Health, Inc. (U.S.), COSMED srl (Italy), NIHON KOHDEN CORPORATION (Japan), and others.

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India

This release was published on openPR.